medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2021, Number 1

<< Back Next >>

Alerg Asma Inmunol Pediatr 2021; 30 (1)

Socio-environmental risk factors associated with the presence of atopia symptoms in children under 3 years old

Beltrán J, Zurita C, Romero P

Language: Spanish
References: 27
Page: 13-18
PDF size: 176.41 Kb.


ABSTRACT

Atopias are a group of diseases that is gaining day-to-day research, with technological improvements that have allowed us to expand molecular studies of the environmental causes that can develop an allergic syndrome in a child. This study seeks to determine the socio-environmental risk factors associated with the presence of atopic symptoms in children under three years of age born in the General Hospital "San Francisco". Material and methods: This is an observational, retrospective, longitudinal and inferential study. clinical histories of the year 2017 of the Neonatology service of the General Hospital "San Francisco", an adapted questionnaire of ISAAC-III was carried out, focusing on perinatal, family, social and environmental factors. Results: The frequency of presentation was allergic rhinitis 27.1%, atopic dermatitis 24%, food allergy 10.5%, asthma 9%. A risk association was made with the allergic family member obtaining OR: 2.15 (1.06-4.35) p = 0.03. The use of antibiotics before the first year had an OR 2.47 (1.21-5.05) p = 0.01. Regarding temporality, the rainy season was associated with a higher intensity of atopic symptoms, with OR: 5.6 (95% 1.95-16.03) p = 0.01, obtaining the same association for asthma, atopic dermatitis, and in the dry season for allergic rhinitis. Conclusions: The socioenvironmental factors associated with the risk of development of atopias were allergic family, antibiotic therapy in the first year of life, and rainy season in Quito and dry season for atopic dermatitis.


REFERENCES

  1. Reddel HK. GINA report: global strategy for asthma management and prevention. 2018 [Internet]. 2018 [citado 20 de agosto de 2018]; Available in: https://ginasthma.org.

  2. To T, Gershon A, Wang C, Dell S, Cicutto L. Persistence and remission in childhood asthma: a population-based asthma birth cohort study. Arch Pediatr Adolesc Med. 2007; 161 (12): 1197-1204.

  3. Peñaranda A, Aristizabal G, García E, Vásquez C, Rodríguez-Martinez CE. Rhinoconjunctivitis prevalence and associated factors in school children aged 6-7 and 13-14 years old in Bogota, Colombia. Int J Pediatr Otorhinolaryngol. 2012; 76 (4): 530-535.

  4. Bousquet J, Gern JE, Martinez FD, Anto JM, Johnson CC, Holt PG et al. Birth cohorts in asthma and allergic diseases: report of a NIAID, NHLBI, MeDALL joint workshop. J Allergy Clin Immunol. 2014; 133: 1535-1546. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088262/.

  5. Avilés DS. Prevalencia de enfermedades alérgicas en el servicio de alergología e inmunología en pacientes de 4-20 años de edad del Hospital de Especialidades de las Fuerzas Armadas N°1 desde enero 2017 a abril 2017". 2017; [citado 13 de noviembre de 2018]; Disponible en: http://repositorio.puce.edu.ec:80/xmlui/handle/22000/13979.

  6. Garrote A, Bonet R. Alergias y antialérgicos. Causas, tipos y tratamiento. Offarm. 2004; 23 (3): 82-92.

  7. Hammersley VS, Harris J, Sheikh A, Davidson E, Walker S. Developing and testing of a screening tool to predict people without IgE-mediated allergy: a quantitative analysis of the predictive value of a screening tool. Br J Gen Pract. 2017; 67 (657): e293-299.

  8. Lee SY, Lee E, Park YM, Hong SJ. Microbiome in the gut-skin axis in atopic dermatitis. Allergy Asthma Immunol Res. 2018; 10 (4): 354-362.

  9. Sandhu KV, Sherwin E, Schellekens H, Stanton C, Dinan TG, Cryan JF. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl Res. 2017; 179: 223-244.

  10. Kim S, Jazwinski SM. The gut microbiota and healthy aging: a mini-review. Gerontology. 2018; 64 (6): 513-520.

  11. Belkaid Y, Hand T. Role of the microbiota in immunity and inflammation. Cell. 2014; 157 (1): 121-141.

  12. Oosterloo BC, van Elburg RM, Rutten NB, Bunkers CM, Crijns CE, Meijssen CB et al. Wheezing and infantile colic are associated with neonatal antibiotic treatment. Pediatr Allergy Immunol. 2018; 29 (2): 151-158.

  13. Mitchell. EU action on antimicrobial resistance - antimicrobial resistance - european commission. [Internet]. Antimicrobial Resistance. 2017; [citado 20 de julio de 2018]. Available in: /health/amr/antimicrobial-resistance_en.

  14. Zhang Q, Cox M, Liang Z, Brinkmann F, Cardenas PA, Duff R et al. Airway microbiota in severe asthma and relationship to asthma severity and phenotypes. PLoS ONE. 2016; 11 (4).

  15. Palacios VML, Zavalu VMC. Algunas expectaciones acerca del asma. Dominio Las Cienc. 2018; 4 (1): 17-27.

  16. Lima RG, Pastorino AC, Casagrande RRD, Sole D, Leone C, Jacob CMA. Prevalence of asthma, rhinitis and eczema in 6-7 years old students from the western districts of São Paulo City, using the standardized questionnaire of the "International Study of Asthma and Allergies in Childhood" (ISAAC)-phase IIIB. Clinics (Sao Paulo Braz). 2007; 62 (3): 225-234.

  17. Tseng WN, Chen CC, Yu HR, Huang LT, Kuo HC. Antenatal dexamethasone exposure in preterm infants is associated with allergic diseases and the mental development index in children. Int J Environ Res Public Health. 2016; 13 (12): 1206.

  18. Tseng CJ, Sun DP, Lee IC, Weng SF, Chou CL. Factors associated with small bowel obstruction following appendectomy: a population-based study. Medicine (Baltimore). 2016; 95 (18): e3541.

  19. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet Lond Engl. 1998; 351 (9111): 1225-1232.

  20. Barba S, Lascano G, Naranjo VP, Landazuri N, Morales M, Alvarez F et al. La Dermatitis Atópica en Quito y el Ecuador. Rev Ecuat Med Cienc Biológicas. 2011; 32: 11-23.

  21. Kliegman RM, Stanton BMD, Geme JS, Schor NF. Nelson tratado de pediatría. Elsevier España; 2016. p. 11582.

  22. Leffler J, Read JF, Jones AC, Mok D, Hollams EM, Laing IA et al. Progressive increase of FcεRI expression across several PBMC subsets is associated with atopy and atopic asthma within school-aged children. Pediatr Allergy Immunol. 2019; 30 (6): 646-653.

  23. Sobko T, Schiött J, Ehlin A, Lundberg J, Montgomery S, Norman M. Neonatal sepsis, antibiotic therapy and later risk of asthma and allergy. Paediatr Perinat Epidemiol. 2010; 24 (1): 88-92.

  24. Mitre E, Susi A, Kropp LE, Schwartz DJ, Gorman GH, Nylund CM. Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood. JAMA Pediatr. 2018; 172 (6): e180315.

  25. Nicklas TA, O'Neil CE, Fulgoni VL. Nutrient intake, introduction of baby cereals and other complementary foods in the diets of infants and toddlers from birth to 23 months of age. AIMS Public Health. 2020; 7 (1): 123-147.

  26. Ojwang V, Nwaru BI, Takkinen HM, Kaila M, Niemelä O, Haapala AM et al. Early exposure to cats, dogs and farm animals and the risk of childhood asthma and allergy. Pediatr Allergy Immunol. 2020; 31 (3): 265-272.

  27. Bonamonte D, Filoni A, Vestita M, Romita P, Foti C, Angelini G. The role of the environmental risk factors in the pathogenesis and clinical outcome of atopic dermatitis. Bio Med Res Int. 2019; 2019: 2450605.




2020     |     www.medigraphic.com